Comparison between Senores Pharmaceuticals IPO and Ventive Hospitality IPO.
Senores Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ventive Hospitality IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Senores Pharmaceuticals IPO is up to ₹582.11 Cr whereas the issue size of the Ventive Hospitality IPO is up to ₹1,600.00 Cr. The final issue price of Senores Pharmaceuticals IPO is ₹391.00 per share and of Ventive Hospitality IPO is ₹643.00 per share.
| Senores Pharmaceuticals IPO | Ventive Hospitality IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹372.00 per share | ₹610.00 per share |
| Issue Price (Upper) | ₹391.00 per share | ₹643.00 per share |
| Issue Price (Final) | ₹391.00 per share | ₹643.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹30.00 per share |
| Market Lot Size | 38 shares | 23 shares |
| Fresh Issue Size | 1,27,87,723 shares | 2,48,83,778 shares |
| Fresh Issue Size (Amount) | up to ₹500.00 Cr | up to ₹1,600.00 Cr |
| OFS Issue Size | 21,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹82.11 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,48,87,723 shares | 2,48,83,778 shares |
| Issue Size Total (Amount) | up to ₹582.11 Cr | up to ₹1,600.00 Cr |
Senores Pharmaceuticals IPO opens on Dec 20, 2024, while Ventive Hospitality IPO opens on Dec 20, 2024. The closing date of Senores Pharmaceuticals IPO and Ventive Hospitality IPO is Dec 24, 2024, and Dec 24, 2024, respectively.
| Senores Pharmaceuticals IPO | Ventive Hospitality IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2024 | Dec 19, 2024 |
| Issue Open | Dec 20, 2024 | Dec 20, 2024 |
| Issue Close | Dec 24, 2024 | Dec 24, 2024 |
| Basis Of Allotment (Tentative) | Dec 26, 2024 | Dec 26, 2024 |
| Initiation of Refunds (Tentative) | Dec 27, 2024 | Dec 27, 2024 |
| Credit of Share (Tentative) | Dec 27, 2024 | Dec 27, 2024 |
| Listing date (Tentative) | Dec 30, 2024 | Dec 30, 2024 |
| Anchor Lockin End date 1 | Jan 24, 2025 | Jan 24, 2025 |
| Anchor Lockin End date 2 | Mar 25, 2025 | Mar 25, 2025 |
Senores Pharmaceuticals IPO P/E ratio is 39.77, as compared to Ventive Hospitality IPO P/E ratio of -201.01.
| Senores Pharmaceuticals IPO | Ventive Hospitality IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Proforma Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.67 | 99.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 45.77 | 88.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39.77 | -201.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1350.70 Cr. | ₹15016.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.83 | ₹-3.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.60% | -1.82% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Senores Pharmaceuticals IPO Retail Individual Investors (RII) are offered 14,81,272 shares while in Ventive Hospitality IPO retail investors are offered 14,81,272 shares. Qualified Institutional Buyers (QIB) are offered 44,43,818 shares in Senores Pharmaceuticals IPO and 74,60,343 shares in Ventive Hospitality IPO.
| Senores Pharmaceuticals IPO | Ventive Hospitality IPO | |
|---|---|---|
| Anchor Investor Reservation | 66,65,725 shares | 1,11,90,513 shares |
| Market Maker Reservation | ||
| QIB | 44,43,818 shares | 74,60,343 shares |
| NII | 22,21,908 shares | 37,30,171 shares |
| RII | 14,81,272 shares | 24,86,780 shares |
| Employee | 75,000 shares | 16,313 shares |
| Others | ||
| Total | 1,48,87,723 shares | 2,48,84,120 shares |
Senores Pharmaceuticals IPO subscribed 97.86x in total, whereas Ventive Hospitality IPO subscribed 10.33x.
| Senores Pharmaceuticals IPO | Ventive Hospitality IPO | |
|---|---|---|
| QIB (times) | 97.84x | 9.58x |
| NII (times) | 100.35x | 14.60x |
| Big NII (times) | 95.25x | 15.86x |
| Small NII (times) | 111.35x | 12.08x |
| RII (times) | 93.16x | 6.19x |
| Employee (times) | 10.03x | |
| Other (times) | ||
| Total (times) | 97.86x | 10.33x |
